Service de radio-oncologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

712 publications

Sous presse | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ...
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Burtness B., Haddad R., Dinis J., Trigo J., Yokota T., de Souza Viana L., Romanov I., Vermorken J., Bourhis J., Tahara M. et al. JAMA oncology. Peer-reviewed.
Expanding the therapeutic index of radiation therapy by normal tissue protection.
Montay-Gruel P., Meziani L., Yakkala C., Vozenin M.C. The British journal of radiology p. 20180008. Peer-reviewed.
Radiotherapy in the treatment of extracranial hemangiopericytoma/solitary fibrous tumor: Study from the Rare Cancer Network
Krengli Marco, Cena Tiziana, Zilli Thomas, Jereczek-Fossa Barbara A., De Bari Berardino, Villa Freixa Salvador, Kaanders Johannes H.A.M., Torrente Sara, Pasquier David, Sole Claudio V. et al., 2020/03. Radiotherapy and Oncology, 144 pp. 114-120.
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice.
Panje C., Zilli T., Pra A.D., Arnold W., Brouwer K., Garcia Schüler H.I., Gomez S., Herrera F., Khanfir K., Papachristofilou A. et al., 2019/10/16. Radiation oncology, 14 (1) p. 177. Peer-reviewed.
Clinical translation of FLASH radiotherapy: Why and how?
Bourhis J., Montay-Gruel P., Gonçalves Jorge P., Bailat C., Petit B., Ollivier J., Jeanneret-Sozzi W., Ozsahin M., Bochud F., Moeckli R. et al., 2019/10. Radiotherapy and oncology, 139 pp. 11-17. Peer-reviewed.
Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate.
Jorge P.G., Jaccard M., Petersson K., Gondré M., Durán M.T., Desorgher L., Germond J.F., Liger P., Vozenin M.C., Bourhis J. et al., 2019/10. Radiotherapy and oncology, 139 pp. 34-39. Peer-reviewed.
Personnalisation de la dose, du volume et du fractionnement de la radiothérapie du sein [Individual modification of the dose, volume and fractionation of breast radiotherapy]
Bourgier C., Lemanski C., Draghici R., Castan F., Fenoglietto P., Bons F., Farcy-Jacquet M.P., Brengues M., Gourgou S., Ozsahin M. et al., 2019/10. Cancer radiotherapie, 23 (6-7) pp. 778-783. Peer-reviewed.
Treatment of a first patient with FLASH-radiotherapy.
Bourhis J., Sozzi W.J., Jorge P.G., Gaide O., Bailat C., Duclos F., Patin D., Ozsahin M., Bochud F., Germond J.F. et al., 2019/10. Radiotherapy and oncology, 139 pp. 18-22. Peer-reviewed.
Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.
Riesterer O., Frank Ciernik I., Stahel R.A., Xyrafas A., Aebersold D.M., Plasswilm L., Mahmut Ozsahin E., Zwahlen D.R., Nackaerts K., Zimmermann F. et al., 2019/09. Radiotherapy and oncology, 138 pp. 121-125. Peer-reviewed.
Protonthérapie des carcinomes épidermoïdes des voies aérodigestives supérieures : de la physique à la clinique [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic]
Beddok A., Vela A., Calugaru V., Tessonnier T., Kubes J., Dutheil P., Gérard A., Vidal M., Goudjil F., Florescu C. et al., 2019/09. Cancer radiotherapie, 23 (5) pp. 439-448. Peer-reviewed.
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.
Lacombe J., Brengues M., Mangé A., Bourgier C., Gourgou S., Pèlegrin A., Ozsahin M., Solassol J., Azria D., 2019/08/09. Radiation oncology, 14 (1) p. 142. Peer-reviewed.
Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/08. Journal of cancer research and clinical oncology, 145 (8) p. 2167. Peer-reviewed.
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
Dauzier E., Lacas B., Blanchard P., Le Q.T., Simon C., Wolf G., Janot F., Horiuchi M., Tobias J.S., Moon J. et al., 2019/08. Oral oncology, 95 pp. 106-114. Peer-reviewed.
Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken.
Vozenin M.C., Hendry J.H., Limoli C.L., 2019/07. Clinical oncology, 31 (7) pp. 407-415. Peer-reviewed.
Isodose 20 Gy found as a threshold dose for radiation recall dermatitis.
Scher N., Vozenin M.C., Bouchaab H., Ozsahin M., Bourhis J., 2019/07. Clinical and translational radiation oncology, 17 pp. 14-16. Peer-reviewed.
De la construction du bunker à la prise en charge du patient : contrôles qualité des techniques modernes de radiothérapie [From bunker construction to patient treatment: quality controls applied to modern radiotherapy techniques]
Klausner G., Blais E., Martin C., Biau J., Jumeau R., Canova C.H., Lyothier A., Slama Y., Jenny C., Chéa M. et al., 2019/06. Cancer radiotherapie, 23 (3) pp. 248-254. Peer-reviewed.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2019/06. European journal of vascular and endovascular surgery, 57 (6) pp. 859-867. Peer-reviewed.
Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.
Bourgier C., Auperin A., Rivera S., Boisselier P., Petit B., Lang P., Lassau N., Taourel P., Tetreau R., Azria D. et al., 2019/06/01. International journal of radiation oncology, biology, physics, 104 (2) pp. 365-373. Peer-reviewed.
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?
Haefliger S., Milowich D., Sciarra A., Trimeche M., Bouilly J., Kaiser J., Volpi S., Brouland J.P., Sempoux C., de Leval L., 2019/06. Annals of hematology, 98 (6) pp. 1513-1516. Peer-reviewed.
Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients.
Klausner G., Troussier I., Biau J., Jacob J., Schernberg A., Canova C.H., Simon J.M., Borius P.Y., Malouf G., Spano J.P. et al., 2019/06. Clinical genitourinary cancer, 17 (3) pp. 191-200. Peer-reviewed.
TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation.
Petit V., Parcelier A., Mathé C., Barroca V., Torres C., Lewandowski D., Ferri F., Gallouët A.S., Dalloz M., Dinet O. et al., 2019/06. EBioMedicine, 44 pp. 60-70. Peer-reviewed.
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
Montay-Gruel P., Acharya M.M., Petersson K., Alikhani L., Yakkala C., Allen B.D., Ollivier J., Petit B., Jorge P.G., Syage A.R. et al., 2019/05/28. Proceedings of the National Academy of Sciences of the United States of America, 116 (22) pp. 10943-10951. Peer-reviewed.
Prise en charge des tachycardies ventriculaires réfractaires par radiothérapie stéréotaxique [Management of refractory ventricular tachycardia using stereotactic body radiotherapy]
Jumeau R., Bourhis J., Ozsahin M., Vallet V., Zeverino M., Moeckli R., Kinj R., Vozenin M.C., Schwitter J., Herrera-Siklody C. et al., 2019/05/22. Revue medicale suisse, 15 (652) pp. 1082-1086. Peer-reviewed.
"Shared Decision Making Is the Gold Standard"!
Tsoutsou P.P., Belkacemi Y., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 12-13. Peer-reviewed.
In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data.
Schopfer M., Bochud F.O., Bourhis J., Moeckli R., 2019/05. Medical physics, 46 (5) pp. 1963-1971. Peer-reviewed.
Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?
Belkacemi Y., Majdoul S., Tsoutsou P.P., Abouegylah M., Kaidar-Person O., Meattini I., Poortmans PMP, Taghian A., 2019/05/01. International journal of radiation oncology, biology, physics, 104 (1) pp. 10-11. Peer-reviewed.
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).
Curioni-Fontecedro A., Perentes J.Y., Gelpke H., Xyrafas A., Bouchaab H., Mach N., Matzinger O., Stojcheva N., Frueh M., Weder W. et al., 2019/05. British journal of cancer, 120 (10) pp. 968-974. Peer-reviewed.
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
Biau J., Lapeyre M., Troussier I., Budach W., Giralt J., Grau C., Kazmierska J., Langendijk J.A., Ozsahin M., O'Sullivan B. et al., 2019/05. Radiotherapy and oncology, 134 pp. 1-9. Peer-reviewed.
Emerging patient-specific treatment modalities in head and neck cancer - a systematic review.
Elicin O., Cihoric N., Vlaskou Badra E., Ozsahin M., 2019/04. Expert opinion on investigational drugs, 28 (4) pp. 365-376. Peer-reviewed.
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
De Bari B., Franzetti-Pellanda A., Saidi A., Biggiogero M., Hahnloser D., Montemurro M., Bourhis J., Zeverino M., Ozsahin M., 2019/04. Journal of cancer research and clinical oncology, 145 (4) pp. 1075-1084. Peer-reviewed.
Prostate cancer: On the road of progress.
Bolla M., Mirimanoff R.O., 2019/04. Asian journal of urology, 6 (2) pp. 123-124. Peer-reviewed.
Lung Adenocarcinoma Metastasis to the Prostate: A Case Report.
Gilmour N., Mampuya W.A., Jumeau R., Dattner N., Ozsahin M., 2019/03. Practical radiation oncology, 9 (2) pp. 77-80. Peer-reviewed.
PET-based prognostic survival model after radiotherapy for head and neck cancer.
Castelli J., Depeursinge A., Devillers A., Campillo-Gimenez B., Dicente Y., Prior J.O., Chajon E., Jegoux F., Sire C., Acosta O. et al., 2019/03. European journal of nuclear medicine and molecular imaging, 46 (3) pp. 638-649. Peer-reviewed.
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019.
Belkacemi Y., Sio T.T., Colson-Durand L., Onal C., Villà S., Anacak Y., Krengli M., Thariat J., Ugurluer G., Miller R.C. et al., 2019/03. Critical reviews in oncology/hematology, 135 pp. 8-19. Peer-reviewed.
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
Chimioradiothérapie des cancers de l’œsophage : revue critique de la littérature [Chemoradiation for oesophageal cancer: A critical review of the literature]
Blais E., Vendrely V., Sargos P., Créhange G., Huguet F., Maingon P., Simon J.M., Bourdais R., Ozsahin M., Bourhis J. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 62-72. Peer-reviewed.
Mise en place d’une politique de qualité et de sécurité lors de l’installation d’un nouvel équipement dans un service de radiothérapie [Quality and safety policy implementation for a new radiotherapy device]
Martin C., Jumeau R., Blais E., Canova C.H., Klausner G., Dumas R., Rouger A., Pariente F., Lyothier A., Slama Y. et al., 2019/02. Cancer radiotherapie, 23 (1) pp. 50-57. Peer-reviewed.
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
Peters S., Dafni U., Boyer M., De Ruysscher D., Faivre-Finn C., Felip E., Garrido P., Girard N., Guckenberger M., Haanen J. et al., 2019/02/01. Annals of oncology, 30 (2) pp. 161-165. Peer-reviewed.
Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers.
Biau J., Dunet V., Lapeyre M., Simon C., Ozsahin M., Grégoire V., Bourhis J., 2019/02. Radiotherapy and oncology, 131 pp. 192-201. Peer-reviewed.
Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer.
Tsoutsou P.G., Vozenin M.C., 2019/01/01. JAMA oncology, 5 (1) pp. 111-112. Peer-reviewed.
Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice.
Szturz P., Cristina V., Herrera Gómez R.G., Bourhis J., Simon C., Vermorken J.B., 2019. Frontiers in oncology, 9 p. 464. Peer-reviewed.
Gamma Knife radiosurgery for intravestibular and intracochlear schwannomas.
Tuleasca C., George M., Schiappacasse L., Patin D., Fenu J., Maire R., Levivier M., 2019/01. Acta neurochirurgica, 161 (1) pp. 63-67. Peer-reviewed.
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01).
Früh M., Betticher D.C., Stupp R., Xyrafas A., Peters S., Ris H.B., Mirimanoff R.O., Ochsenbein A.F., Schmid R., Matzinger O. et al., 2019/01. Journal of thoracic oncology, 14 (1) pp. 115-123. Peer-reviewed.
The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.
Vozenin M.C., De Fornel P., Petersson K., Favaudon V., Jaccard M., Germond J.F., Petit B., Burki M., Ferrand G., Patin D. et al., 2019/01/01. Clinical cancer research, 25 (1) pp. 35-42. Peer-reviewed.
Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.
Kyroudi A., Petersson K., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 318-324. Peer-reviewed.
Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.
Conrad M., Bolard G., Nowak M., De Bari B., Jeanneret-Sozzi W., Bourhis J., Germond J.F., Bochud F., Moeckli R., 2018/12. Zeitschrift fur medizinische Physik, 28 (4) pp. 276-285. Peer-reviewed.
Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability.
Tas B., Durmus I.F., Okumus A., Uzel O.E., Gokce M., Goksoy H.S., Ozsahin E.M., 2018/12. Radiotherapy and oncology, 129 (3) pp. 527-533. Peer-reviewed.
X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.
Montay-Gruel P., Bouchet A., Jaccard M., Patin D., Serduc R., Aim W., Petersson K., Petit B., Bailat C., Bourhis J. et al., 2018/12. Radiotherapy and oncology, 129 (3) pp. 582-588. Peer-reviewed.
Clinical Outcomes of Rectal Squamous Cell Carcinomas Treated with Chemoradiotherapy with or Without Surgery: A Rare Cancer Network Study.
De Bari B., Aloi D., Lemanski C., Hallemeier C.L., Touboul E., Qi S., Christie D., Vees H., Shulman K., Atasoy B.M. et al., 2018/11. International Journal of Radiation Oncology*Biology*Physics, 102 (3) pp. e3-e4.
Adaptive radiotherapy for head and neck cancer.
Castelli J., Simon A., Lafond C., Perichon N., Rigaud B., Chajon E., De Bari B., Ozsahin M., Bourhis J., de Crevoisier R., 2018/10. Acta oncologica, 57 (10) pp. 1284-1292. Peer-reviewed.
The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.
Daniel R.T., Tuleasca C., Rocca A., George M., Pralong E., Schiappacasse L., Zeverino M., Maire R., Messerer M., Levivier M., 2018/10. Journal of neurological surgery. Part B, Skull base, 79 (Suppl 4) pp. S362-S370. Peer-reviewed.
Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review.
Feutren T., Herrera F.G., 2018/09. Prostate international, 6 (3) pp. 75-87. Peer-reviewed.
Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
Tao Y., Faivre L., Laprie A., Boisselier P., Ferron C., Jung G.M., Racadot S., Gery B., Even C., Breuskin I. et al., 2018/09. Radiotherapy and oncology, 128 (3) pp. 467-471. Peer-reviewed.
Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.
Klausner G., Blais E., Jumeau R., Biau J., de Meric de Bellefon M., Ozsahin M., Zilli T., Miralbell R., Thariat J., Troussier I., 2018/08/20. Medical oncology, 35 (10) p. 134. Peer-reviewed.
Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.
Jumeau R., Ozsahin M., Schwitter J., Vallet V., Duclos F., Zeverino M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) pp. 189-191. Peer-reviewed.
Response to Spartalis et al.
Jumeau R., Ozsahin M., Moeckli R., Pruvot E., Bourhis J., 2018/08. Radiotherapy and oncology, 128 (2) p. 388. Peer-reviewed.
A treatment planning comparison of contemporary photon-based radiation techniques for breast cancer
Zeverino Michele, Petersson Kristoffer, Kyroudi Archonteia, Jeanneret-Sozzi Wendy, Bourhis Jean, Bochud Francois, Moeckli Raphael, 2018/07. Physics and Imaging in Radiation Oncology, 7 pp. 32-38.
In Regard to Pereira et al.
Azria D., Gourgou S., Brengues M., Bourgier C., Ozsahin M., 2018/06/01. International journal of radiation oncology, biology, physics, 101 (2) pp. 490-491. Peer-reviewed.
(<sup>18</sup>F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.
Scher N., Castelli J., Depeursinge A., Bourhis J., Prior J.O., Herrera F.G., Ozsahin M., 2018/05. Cancer radiotherapie, 22 (3) pp. 229-235. Peer-reviewed.
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun X.S., Michel C., Babin E., De Raucourt D., Péchery A., Gherga E., Géry B., Florescu C., Bourhis J., Thariat J., 2018/04. Future oncology, 14 (9) pp. 877-889. Peer-reviewed.
Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B., Lestrade L., Franzetti-Pellanda A., Jumeau R., Biggiogero M., Kountouri M., Matzinger O., Miralbell R., Bourhis J., Ozsahin M. et al., 2018/04. Journal of cancer research and clinical oncology, 144 (4) pp. 781-789. Peer-reviewed.
Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase™ training tool.
De Bari B., Dahele M., Palmu M., Kaylor S., Schiappacasse L., Guckenberger M., ESTRO FALCON core, 2018/04. Radiotherapy and oncology, 127 (1) pp. 150-153. Peer-reviewed.
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., Erpolat P., Negretti L., Lassen-Ramshad Y., Onal C. et al., 2018/04. Radiotherapy and oncology, 127 (1) pp. 96-102. Peer-reviewed.
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Bourgier C., Castan F., Riou O., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2018/03/20. Oncotarget, 9 (21) pp. 15757-15765. Peer-reviewed.
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).
Frikha M., Auperin A., Tao Y., Elloumi F., Toumi N., Blanchard P., Lang P., Sun S., Racadot S., Thariat J. et al., 2018/03/01. Annals of oncology, 29 (3) pp. 731-736. Peer-reviewed.
Comparison of 3DCRT and VMAT treatment in neoadjuvant oesophageal cancer.
Santa Cruz O (eds.), 2018/03., 92 Suppl 2.
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages.
Meziani L., Mondini M., Petit B., Boissonnas A., Thomas de Montpreville V., Mercier O., Vozenin M.C., Deutsch E., 2018/03. The European respiratory journal, 51 (3) pp. NA. Peer-reviewed.
Gamma Knife radiosurgery for glossopharyngeal neuralgia: A study of 21 patients with long-term follow-up.
Borius P.Y., Tuleasca C., Muraciole X., Negretti L., Schiappacasse L., Dorenlot A., Marguet M., Zeverino M., Donnet A., Levivier M. et al., 2018/03. Cephalalgia, 38 (3) pp. 543-550. Peer-reviewed.
Toxicité cardiaque de la radiothérapie : une réalité à prendre en compte [Cardiac toxicity induced by radiation therapy: a reality to consider]
Vozenin M.C., 2018/03. La Revue du praticien, 68 (3) pp. 330-331. Peer-reviewed.
High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.
Jaccard M., Durán M.T., Petersson K., Germond J.F., Liger P., Vozenin M.C., Bourhis J., Bochud F., Bailat C., 2018/02. Medical physics, 45 (2) pp. 863-874. Peer-reviewed.
A need for biology-driven personalized radiotherapy in breast cancer.
Tsoutsou P.G., Durham A.D., Vozenin M.C., 2018/01. Breast cancer research and treatment, 167 (2) pp. 603-604. Peer-reviewed.
Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy.
Boivin G., Kalambaden P., Faget J., Rusakiewicz S., Montay-Gruel P., Meylan E., Bourhis J., Lesec G., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 256. Peer-reviewed.
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V., Evans M., Le Q.T., Bourhis J., Budach V., Chen A., Eisbruch A., Feng M., Giralt J., Gupta T. et al., 2018/01. Radiotherapy and oncology, 126 (1) pp. 3-24. Peer-reviewed.
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.
Tsoutsou P.G., Zaman K., Martin Lluesma S., Cagnon L., Kandalaft L., Vozenin M.C., 2018. Frontiers in oncology, 8 p. 609. Peer-reviewed.
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
Maria ATJ, Toupet K., Maumus M., Rozier P., Vozenin M.C., Le Quellec A., Jorgensen C., Noël D., Guilpain P., 2018. Frontiers in immunology, 9 p. 2571. Peer-reviewed.
Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
De Bari B., Breuneval T., Zeverino M., Godin S., Deantonio L., Geldhof C., Bourhis J., Schaefer N., Moeckli R., Prior J. et al., 2018. PloS one, 13 (10) pp. e0204013. Peer-reviewed.
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Tao Y., Auperin A., Sire C., Martin L., Khoury C., Maingon P., Bardet E., Kaminsky M.C., Lapeyre M., Chatellier T. et al., 2018. Journal of clinical oncology, 36 ( 31) pp. 3084-3090. Peer-reviewed.
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Geoffrois L., Martin L., De Raucourt D., Sun X.S., Tao Y., Maingon P., Buffet J., Pointreau Y., Sire C., Tuchais C. et al., 2018. Journal of clinical oncology, 36 (31) pp. 3077-3083. Peer-reviewed.
Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O., Tsoutsou P., Castella C., Khanfir K., Anchisi S., Bouayed S., Matzinger O., Ozsahin M., 2018. Oncology, 95 (2) pp. 61-68. Peer-reviewed.
Salvage-Radiotherapie bei makroskopischen Lokalrezidiven nach radikaler Prostatektomie : Nationale Umfrage zu Behandlungsmustern [Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice]
Dal Pra A., Panje C., Zilli T., Arnold W., Brouwer K., Garcia H., Glatzer M., Gomez S., Herrera F., Kaouthar K. et al., 2018/01. Strahlentherapie und Onkologie, 194 (1) pp. 9-16. Peer-reviewed.
Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report.
De Bari B., Vallati M., Gatta R., Lestrade L., Manfrida S., Carrie C., Valentini V., 2017/12/12. Oncotarget, 8 (65) pp. 108509-108521. Peer-reviewed.
Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.
Faget J., Groeneveld S., Boivin G., Sankar M., Zangger N., Garcia M., Guex N., Zlobec I., Steiner L., Piersigilli A. et al., 2017/12/12. Cell reports, 21 (11) pp. 3190-3204. Peer-reviewed.
Letter: Cystic Vestibular Schwannomas Respond Best to Radiosurgery.
Tuleasca C., George M., Maire R., Schiappacasse L., Marguet M., Daniel R.T., Levivier M., 2017/12/01. Neurosurgery, 81 (6) pp. E80-E82. Peer-reviewed.
Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.
Pellanda A.F., De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., Villà S., Goldberg H., Szutowicz-Zielińska E., Bolla M. et al., 2017/12. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 29 (6) pp. 521-532. Peer-reviewed.
Radiosurgery in trochlear and abducens nerve schwannomas: case series and systematic review.
Peciu-Florianu I., Tuleasca C., Comps J.N., Schiappacasse L., Zeverino M., Daniel R.T., Levivier M., 2017/12. Acta neurochirurgica, 159 (12) pp. 2409-2418. Peer-reviewed.
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.
Ghadjar P., Hayoz S., Genitsch V., Zwahlen D.R., Hölscher T., Gut P., Guckenberger M., Hildebrandt G., Müller A.C., Putora P.M. et al., 2017/11. BJU international, 120 (5B) pp. E45-E51. Peer-reviewed.
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y., Auperin A., Sire C., Martin M., Saliou M.G., Bardet E., Sun X.S., Chatellier T., Morand C., Cornely A. et al., 2017/11/01. International journal of radiation oncology, biology, physics, 99 (3) pp. 590-595. Peer-reviewed.
Contraintes de dose en radiothérapie conformationnelle fractionnée et en radiothérapie stéréotaxique dans les hippocampes, le tronc cérébral et l’encéphale : limites et perspectives [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives]
Gérard M., Jumeau R., Pichon B., Biau J., Blais E., Horion J., Noël G., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 636-647. Peer-reviewed.
Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy]
Blais E., Pichon B., Mampuya A., Antoine M., Lagarde P., Kantor G., Breton-Callu C., Lefebvre C., Gerard M., Aamarcha A. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 584-596. Peer-reviewed.
Présentation de l’étude Gortec 2017-03 : radiothérapie en conditions stéréotaxiques postopératoire des cancers localisés de l’oropharynx et de la cavité buccale avec marges à risque (PHRC-K-16-164) [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]
Biau J., Miroir J., Millardet C., Saroul N., Pham-Dang N., Racadot S., Huguet F., Kwiatkowski F., Pereira B., Bourhis J. et al., 2017/10. Cancer radiotherapie, 21 (6-7) pp. 527-532. Peer-reviewed.
Erratum to "Hypofractionated Radiotherapy in pancreatic cancer: lessons from the past in the era of Stereotactic Body Radiation Therapy" [Critical Reviews in Oncology / Hematology 103C (2016) 49-61].
Berardino B., Laetitia P., Rosario M., Filippo A., Dorothea W.A., Markus S., Jean B., Mahmut O., 2017/09..
Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.
Montay-Gruel P., Petersson K., Jaccard M., Boivin G., Germond J.F., Petit B., Doenlen R., Favaudon V., Bochud F., Bailat C. et al., 2017/09. Radiotherapy and oncology, 124 (3) pp. 365-369. Peer-reviewed.
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Lacas B., Bourhis J., Overgaard J., Zhang Q., Grégoire V., Nankivell M., Zackrisson B., Szutkowski Z., Suwiński R., Poulsen M. et al., 2017/09. The Lancet. Oncology, 18 (9) pp. 1221-1237. Peer-reviewed.
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Blumenthal D.T., Gorlia T., Gilbert M.R., Kim M.M., Burt Nabors L., Mason W.P., Hegi M.E., Zhang P., Golfinopoulos V., Perry J.R. et al., 2017/08/01. Neuro-oncology, 19 (8) pp. 1119-1126. Peer-reviewed.
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Salas S., Resseguier N., Blay J.Y., Le Cesne A., Italiano A., Chevreau C., Rosset P., Isambert N., Soulie P., Cupissol D. et al., 2017/08/01. Annals of oncology, 28 (8) pp. 1979-1987. Peer-reviewed.
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Salas S., Resseguier N., Blay J.Y., Le Cesne A., Italiano A., Chevreau C., Rosset P., Isambert N., Soulie P., Cupissol D. et al., 2017/08/01. Annals of oncology, 28 (8) pp. 1979-1987. Peer-reviewed.
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y., Aupérin A., Graff P., Lapeyre M., Grégoire V., Maingon P., Geoffrois L., Verrelle P., Calais G., Gery B. et al., 2017/08. Oral oncology, 71 pp. 61-66. Peer-reviewed.
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy
Petersson Kristoffer, Kyroudi Archonteia, Bourhis Jean, Ceberg Crister, Knöös Tommy, Bochud François, Moeckli Raphaël, 2017/07. Physics and Imaging in Radiation Oncology, 3 pp. 53-56.
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.
De Bari B., Stish B., Ball M.W., Habboush Y., Sargos P., Krengli M., Bossi A., Stabile A., Sole Pesutic C., Lestrade L. et al., 2017/07. The Prostate, 77 (10) pp. 1160-1166. Peer-reviewed.
Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.
Lestrade L., Zilli T., Kountouri M., Jumeau R., Matzinger O., Bourhis J., Miralbell R., Ozsahin M., De Bari B., 2017/07. Clinical oncology, 29 (7) pp. e105-e109. Peer-reviewed.
Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.
Daniel R.T., Tuleasca C., George M., Pralong E., Schiappacasse L., Zeverino M., Maire R., Levivier M., 2017/07. Acta neurochirurgica, 159 (7) pp. 1197-1211. Peer-reviewed.
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
Herrmann E., Mertineit N., De Bari B., Hoeng L., Caparotti F., Leiser D., Jumeau R., Cihoric N., Jensen A.D., Aebersold D.M. et al., 2017/06/14. Radiation oncology, 12 (1) p. 97. Peer-reviewed.
Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?
Castelli J., Depeursinge A., de Bari B., Devillers A., de Crevoisier R., Bourhis J., Prior J.O., 2017/06. Clinical nuclear medicine, 42 (6) pp. e281-e285. Peer-reviewed.
Cancer du sein de stade précoce : la désescalade thérapeutique sélective [Selective therapeutic de-escalation in early stage breast cancer]
Liapi A., Sarivalasis A., Jeanneret Sozzi W., Lelièvre L., Zaman K., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1035-1038. Peer-reviewed.
Cancers de la sphère ORL : l’immunothérapie donne de la voix ! [Head and neck cancer : promising results of immunotherapy]
Sivade A., Bensaid D., Monnier Y., Shabafrouz K., Bouchaab H., Cristina V., 2017/05/17. Revue medicale suisse, 13 (563) pp. 1029-1031. Peer-reviewed.
Minimizing adjuvant treatment after transoral robotic surgery through surgical margin revision and exclusion of radiographic extracapsular extension: A Prospective observational cohort study.
Morisod B., Venara-Vulpe I.I., Alzuphar S., Monnier Y., Bongiovanni M., Hagmann P., Bouchaab H., Bourhis J., Simon C., 2017/05. Head & neck, 39 (5) pp. 965-973. Peer-reviewed.
OC-0125: Relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 trial
Ghadjar P., Hayoz S., Genitsch V., Zwahlen D., Hölscher T., Gut P., Guckenberger M., Hildebrandt G., Müller A.C., Putora M. et al., 2017/05. Radiotherapy and Oncology, 123 pp. S58-S59.
TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.
Tsoutsou P., Annibaldi A., Viertl D., Ollivier J., Buchegger F., Vozenin M.C., Bourhis J., Widmann C., Matzinger O., 2017/05. Radiation research, 187 (5) pp. 562-569. Peer-reviewed.
A PET-based nomogram for oropharyngeal cancers.
Castelli J., Depeursinge A., Ndoh V., Prior J.O., Ozsahin M., Devillers A., Bouchaab H., Chajon E., de Crevoisier R., Scher N. et al., 2017/04. European journal of cancer, 75 pp. 222-230. Peer-reviewed.
Commissioning of the Leksell Gamma Knife(®) Icon™.
Zeverino M., Jaccard M., Patin D., Ryckx N., Marguet M., Tuleasca C., Schiappacasse L., Bourhis J., Levivier M., Bochud F.O. et al., 2017/04. Medical physics, 44 (2) pp. 355-363. Peer-reviewed.
High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.
Jaccard M., Petersson K., Buchillier T., Germond J.F., Durán M.T., Vozenin M.C., Bourhis J., Bochud F.O., Bailat C., 2017/04. Medical physics, 44 (2) pp. 725-735. Peer-reviewed.
Les promesses du haut débit de dose en radiothérapie [Hopes of high dose-rate radiotherapy]
Fouillade C., Favaudon V., Vozenin M.C., Romeo P.H., Bourhis J., Verrelle P., Devauchelle P., Patriarca A., Heinrich S., Mazal A. et al., 2017/04. Bulletin du cancer, 104 (4) pp. 380-384. Peer-reviewed.
Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study.
Ogna A., Bernasconi M., Belmondo B., Long O., Simons J., Peguret N., Heinzer R., Nicod L.P., Bourhis J., Lovis A., 2017/04/01. American journal of respiratory and critical care medicine, 195 (7) pp. 958-960. Peer-reviewed.
Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer.
Jumeau R., Peguret N., de Bari B., Moeckli R., Soares-Rodrigues J.L., Durham A.D., Hojnowski S., Bourhis J., Ozsahin M., Beigelman-Aubry C., 2017/04. Journal of medical imaging and radiation oncology, 61 (2) pp. 252-257. Peer-reviewed.
Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.
Rotolo F., Pignon J.P., Bourhis J., Marguet S., Leclercq J., Tong Ng W., Ma J., Chan A.T., Huang P.Y., Zhu G. et al., 2017/04. Journal of the National Cancer Institute, 109 (4) pp. 1-9. Peer-reviewed.
High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.
Petersson K., Jaccard M., Germond J.F., Buchillier T., Bochud F., Bourhis J., Vozenin M.C., Bailat C., 2017/03. Medical physics, 44 (3) pp. 1157-1167. Peer-reviewed.
Implementation of TomoEDGE in the independent dose calculator CheckTomo.
Schopfer M., Thomas S.J., Tudor G.S., Bourhis J., Bochud F., Moeckli R., 2017/03. Journal of applied clinical medical physics, 18 (2) pp. 92-99. Peer-reviewed.
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.
Alongi F., Arcangeli S., De Bari B., Giaj-Levra N., Fiorentino A., Mazzola R., Trovò M., 2017/03. Critical reviews in oncology/hematology, 112 pp. 67-71. Peer-reviewed.
The latest prospects of investigational drugs for head and neck cancer.
Elicin O., Ozsahin M., 2017/03. Expert opinion on investigational drugs, 26 (3) pp. 265-268. Peer-reviewed.
Abstract P6-09-52: Prognostic factors in breast cancer (BC) associated with the development of brain metastases (BM): A retrospective study of 726 pts
Santa Cruz O, Tsoutsou P, Anchisi S, Khanfir K, Negretti L, Girardet C, Ozsoy O, Ozsahin M, 2017/02/15. Poster Session Abstracts.
Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?
De Bari B., Durham A., Bourhis J., Ozsahin M., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 573-574. Peer-reviewed.
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
Ribassin-Majed L., Marguet S., Lee AWM, Ng W.T., Ma J., Chan ATC, Huang P.Y., Zhu G., Chua DTT, Chen Y. et al., 2017/02/10. Journal of clinical oncology, 35 (5) pp. 498-505. Peer-reviewed.
How could breast cancer molecular features contribute to locoregional treatment decision making?
Tsoutsou P.G., Vozenin M.C., Durham A.D., Bourhis J., 2017/02. Critical reviews in oncology/hematology, 110 pp. 43-48. Peer-reviewed.
T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M., Lapierre A., Bourgier C., Pèlegrin A., Özsahin M., Azria D., 2017/02. Expert review of molecular diagnostics, 17 (2) pp. 119-127. Peer-reviewed.
Chest-MRI under pulsatile flow ventilation: A new promising technique.
Beigelman-Aubry C., Peguret N., Stuber M., Delacoste J., Belmondo B., Lovis A., Simons J., Long O., Grant K., Berchier G. et al., 2017. PloS one, 12 (6) pp. e0178807. Peer-reviewed.
Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage.
Bayart E., Pouzoulet F., Calmels L., Dadoun J., Allot F., Plagnard J., Ravanat J.L., Bridier A., Denozière M., Bourhis J. et al., 2017. PloS one, 12 (1) pp. e0168395. Peer-reviewed.
Linear-Endobronchial Ultrasound-guided Insertion of a Fiducial Marker: A New Tool for Tracking Central Lesions.
Casutt A., Koutsokera A., Peguret N., Lovis A., 2017. Journal of Bronchology and Interventional Pulmonology, 24 (2) pp. 166-69. Peer-reviewed.
Radiotherapy combination opportunities leveraging immunity for the next oncology practice.
Herrera F.G., Bourhis J., Coukos G., 2017/01. CA: a cancer journal for clinicians, 67 (1) pp. 65-85. Peer-reviewed.
Centre des sarcomes : un nouvel outil pour améliorer la prise en charge du patient et soutenir la recherche [Sarcoma centres : a necessary tool in the management of patients and for research.]
Cherix S., Vauclair F., Morattel B., Vautrin M., Matter M., Montemurro M., Digklia A., Letovanec I., Omoumi P., Saucy F. et al., 2016/12/14. Revue medicale suisse, 12 (543) pp. 2172-2176. Peer-reviewed.
Acute clinical adverse radiation effects after Gamma Knife surgery for vestibular schwannomas.
Tuleasca C., George M., Faouzi M., Schiappacasse L., Leroy H.A., Zeverino M., Daniel R.T., Maire R., Levivier M., 2016/12. Journal of neurosurgery, 125 (Suppl 1) pp. 73-82. Peer-reviewed.
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.
Castelli J., De Bari B., Depeursinge A., Simon A., Devillers A., Roman Jimenez G., Prior J., Ozsahin M., de Crevoisier R., Bourhis J., 2016/12. Critical reviews in oncology/hematology, 108 pp. 40-51. Peer-reviewed.
Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis.
Thengumpallil S., Smith K., Monnin P., Bourhis J., Bochud F., Moeckli R., 2016/11/08. Journal of applied clinical medical physics, 17 (6) p. 6459. Peer-reviewed.
Extreme hypofractionation for early prostate cancer: Biology meets technology.
De Bari B., Arcangeli S., Ciardo D., Mazzola R., Alongi F., Russi E.G., Santoni R., Magrini S.M., Jereczek-Fossa B.A., on the behalf of the Italian Association of Radiation Oncology (AIRO), 2016/11. Cancer treatment reviews, 50 pp. 48-60. Peer-reviewed.
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J., Navarro A., Del Hoyo O., Gomez-Iturriaga A., Alongi F., Medina J.A., Elicin O., Skanjeti A., Giammarile F., Bilbao P. et al., 2016/11. The British journal of radiology, 89 (1067) p. 20160217. Peer-reviewed.
Role of functional imaging in treatment plan optimization of stereotactic body radiation therapy for liver cancer.
De Bari B., Jumeau R., Deantonio L., Adib S., Godin S., Zeverino M., Moeckli R., Bourhis J., Prior J.O., Ozsahin M., 2016/10/13. Tumori, 102 (5) pp. e21-e24. Peer-reviewed.
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial.
Früh M., Ris H.B., Xyrafas A., Peters S., Mirimanoff R.O., Gautschi O., Pless M., Stupp R., 2016/10. Annals of oncology, 27 (10) pp. 1971-1973. Peer-reviewed.
Radiation Therapy for Extracranial Hemangiopericytoma/Solitary Fibrous Tumor: A Study From the Rare Cancer Network
Krengli M., De Bari B., Villa S., Kaanders J.H.A.M., Torrente S., Pasquier D., Thariat J.O., Myroslav L., Sole C.V., Dincbas H.F. et al., 2016/10. pp. E707 dans Proceedings of the 58th Annual Meeting of the American Society for Radiation Oncology, International Journal of Radiation Oncology Biology Physics, American Society for Radiation Oncology.
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?
Jereczek-Fossa B.A., Ciardo D., Petralia G., Bellomi M., De Bari B., De Cobelli O., Orecchia R., 2016/09. Critical reviews in oncology/hematology, 105 pp. 100-111. Peer-reviewed.
Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma.
van der Steen-Banasik E., Christiaens M., Shash E., Coens C., Casado A., Herrera F.G., Ottevanger P.B., European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC-GCG), 2016/09. European journal of cancer, 65 pp. 172-181. Peer-reviewed.
Aromatase inhibitors decrease radiation-induced lung fibrosis: Results of an experimental study.
Altinok A.Y., Yildirim S., Altug T., Sut N., Ober A., Ozsahin E.M., Azria D., Bese N.S., 2016/08. Breast (Edinburgh, Scotland), 28 pp. 174-177. Peer-reviewed.
Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.
Kyroudi A., Petersson K., Ghandour S., Pachoud M., Matzinger O., Ozsahin M., Bourhis J., Bochud F., Moeckli R., 2016/08. Radiotherapy and oncology, 120 (2) pp. 346-348. Peer-reviewed.
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.
De Bari B., Porta L., Mazzola R., Alongi F., Wagner A.D., Schäfer M., Bourhis J., Ozsahin M., 2016/07. Critical reviews in oncology/hematology, 103 pp. 49-61. Peer-reviewed.
Outcome and Predictive Factors in Uterine Carcinosarcoma Using Postoperative Radiotherapy: A Rare Cancer Network Study.
Zwahlen D.R., Schick U., Bolukbasi Y., Thariat J., Abdah-Bortnyak R., Kuten A., Igdem S., Caglar H., Ozsaran Z., Loessl K. et al., 2016/06/28. Rare tumors, 8 (2) p. 6052. Peer-reviewed.
Traitement curatif du cancer de l'oesophage: consensus multidisciplinaire multicentrique [Curative treatment for esophageal cancer: results of a multidisciplinary consensus]
Allemann P., Mantziari S., Wagner D., Digklia A., Ozsahin E., De Bari B., Dorta G., Godat S., Montserrat F., Sempoux C. et al., 2016/06/15. Revue medicale suisse, 12 (523) pp. 1165-1169. Peer-reviewed.
Current Role of Dacomitinib in Head and Neck Cancer.
Elicin O., Ozsahin M., 2016/06. Expert opinion on investigational drugs, 25 (6) pp. 735-742. Peer-reviewed.
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B., Jumeau R., Bouchaab H., Vallet V., Matzinger O., Troussier I., Mirimanoff R.O., Wagner A.D., Hanhloser D., Bourhis J. et al., 2016/06. Acta oncologica (Stockholm, Sweden), 55 (6) pp. 767-773. Peer-reviewed.
Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.
De Bari B., Deantonio L., Bourhis J., Prior J.O., Ozsahin M., 2016/06. Critical reviews in oncology/hematology, 102 pp. 111-117. Peer-reviewed.
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991.
Bolla M., Maingon P., Carrie C., Villa S., Kitsios P., Poortmans P.M., Sundar S., van der Steen-Banasik E.M., Armstrong J., Bosset J.F. et al., 2016/05/20. Journal of clinical oncology, 34 (15) pp. 1748-1756. Peer-reviewed.
Optimization of re-irradiation using deformable registration: a case study
Jumeau Raphaël, Péguret Nicolas, Zulliger Cédric, Moeckli Raphaël, Bourhis Jean, Ozsahin Esat-Mahmut, 2016/05. BJR|case reports, 2 (2) p. 20150412.
Prise en charge des tumeurs cérébrales primaires: une approche multidisciplinaire [Multidisciplinar approach to the management of gliomas]
Moura B., Migliorini D., Bourhis J., Daniel R., Levivier M., Hottinger A.F., 2016/04/27. Revue medicale suisse, 12 (516) pp. 821-825.
[(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
Herrera F.G., Breuneval T., Prior J.O., Bourhis J., Ozsahin M., 2016/03/16. Radiation oncology, 11 p. 43. Peer-reviewed.
Reduction of Respiratory Motion During PET/CT by Pulsatile-Flow Ventilation: A First Clinical Evaluation.
Prior J.O., Péguret N., Pomoni A., Pappon M., Zeverino M., Belmondo B., Lovis A., Ozsahin M., Vienne M., Bourhis J., 2016/03. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57 (3) pp. 416-419. Peer-reviewed.
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?
Arcangeli S., Zilli T., De Bari B., Alongi F., 2016. Critical Reviews In Oncology/hematology, 97 pp. 231-237. Peer-reviewed.
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.
Arcangeli S., Ramella S., De Bari B., Franco P., Alongi F., D'Angelillo R.M., 2016. Critical Reviews In Oncology/hematology, 97 pp. 322-327. Peer-reviewed.
Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
Maria A.T., Toupet K., Bony C., Pirot N., Vozenin M.C., Petit B., Roger P., Batteux F., Le Quellec A., Jorgensen C. et al., 2016. Arthritis and Rheumatology (hoboken, N.j.), 68 (4) pp. 1013-1025. Peer-reviewed.
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.
Péguret N., Ozsahin M., Zeverino M., Belmondo B., Durham A.D., Lovis A., Simons J., Long O., Duclos F., Prior J. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (2) pp. 220-226. Peer-reviewed.
Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
De Bari B., Ozsahin M., Bize P., Boussaha T., Deplanque G., Wagner D., Bourhis J., Denys A., 2016. Journal of Clinical Oncology, 34 (23) pp. 2798-2799. Peer-reviewed.
Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars.
Domergue S., Bony C., Maumus M., Toupet K., Frouin E., Rigau V., Vozenin M.C., Magalon G., Jorgensen C., Noël D., 2016. PloS one, 11 (5) pp. e0156161. Peer-reviewed.
Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial?.
Bourgier C., Kerns S., Gourgou S., Lemanski C., Gutowski M., Fenoglietto P., Romieu G., Crompton N., Lacombe J., Pèlegrin A. et al., 2016. Annals of Oncology, 27 (3) pp. 474-480. Peer-reviewed.
ESTRO-ACROP guideline &quot;target delineation of glioblastomas&quot;.
Niyazi M., Brada M., Chalmers A.J., Combs S.E., Erridge S.C., Fiorentino A., Grosu A.L., Lagerwaard F.J., Minniti G., Mirimanoff R.O. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 118 (1) pp. 35-42. Peer-reviewed.
Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments.
Thengumpallil S., Germond J.F., Bourhis J., Bochud F., Moeckli R., 2016. Radiotherapy and Oncology, 119 (3) pp. 438-443. Peer-reviewed.
Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.
COPERNIC project investigators, Granzotto A., Granzotto A., Benadjaoud M.A., Vogin G., Devic C., Ferlazzo M.L., Bodgi L., Pereira S., Sonzogni L. et al., 2016. International Journal of Radiation Oncology, Biology, Physics, 94 (3) pp. 450-460. Peer-reviewed.
Jaw Immobilization for Gamma Knife Surgery in Patients with Mandibular Lesions: A Newly, Innovative Approach.
Tuleasca C., Broome M., Mosimann P.J., Schiappacasse L., Zeverino M., Dorenlot A., Champoudry J., Régis J., Levivier M., 2016. Stereotactic and functional neurosurgery, 94 (5) pp. 342-347. Peer-reviewed.
Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer.
Qiu B., Ding P.R., Cai L., Xiao W.W., Zeng Z.F., Chen G., Lu Z.H., Li L.R., Wu X.J., Mirimanoff R.O. et al., 2016. Chinese journal of cancer, 35 (1) p. 65. Peer-reviewed.
Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study.
Ugurluer G., Miller R.C., Li Y., Thariat J., Ghadjar P., Schick U., Ozsahin M., 2016. Rare Tumors, 8 (3) p. 6502. Peer-reviewed.
PrP(c) deficiency and dasatinib protect mouse intestines against radiation injury by inhibiting of c-Src.
Strup-Perrot C., Vozenin M.C., Monceau V., Pouzoulet F., Petit B., Holler V., Perrot S., Desquibert L., Fouquet S., Souquere S. et al., 2016. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 120 (1) pp. 175-183. Peer-reviewed.
Radiation Therapy after Radical Prostatectomy: Implications for Clinicians.
Herrera F.G., Berthold D.R., 2016. Frontiers In Oncology, 6 p. 117. Peer-reviewed.
Reply to N.F. Saba and S.J. Wong.
Harrington K.J., Bourhis J., 2016. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 34 (17) pp. 2073-2074. Peer-reviewed.
Spinal metastases: Is stereotactic body radiation therapy supported by evidences?
De Bari B., Alongi F., Mortellaro G., Mazzola R., Schiappacasse L., Guckenberger M., 2016. Critical Reviews In Oncology/hematology, 98 pp. 147-158. Peer-reviewed.
The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?
De Bari B., Franco P., Niyazi M., Cornetto A.P., Qvortrup C., Martin A.N., Cacicedo J., Fernandez G., Louro L.V., Lestrade L. et al., 2016. Technology In Cancer Research and Treatment, 15 (2) pp. 365-376. Peer-reviewed.
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
Ghadjar P., Hayoz S., Bernhard J., Zwahlen D.R., Hölscher T., Gut P., Guckenberger M., Hildebrandt G., Müller A.C., Plasswilm L. et al., 2015/12/10. Journal of clinical oncology, 33 (35) pp. 4158-4166. Peer-reviewed.
A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy.
Cosinschi A., Coskun M., Negretti L., Matzinger O., Jeanneret-Sozzi W., Vallet V., Moeckli R., Mirimanoff R.O., Schiappacasse L., Ozsahin M. et al., 2015/11. Acta oncologica, 54 (10) pp. 1824-1826. Peer-reviewed.
Treatment deintensification and symptom burden in patients with human papillomavirus-associated head and neck cancer.
Ozsahin M., Bourhis J., 2015/11. Cancer, 121 (7) pp. 1147-1148. Peer-reviewed.
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.
Guigay J., Fayette J., Dillies A.F., Sire C., Kerger J.N., Tennevet I., Machiels J.P., Zanetta S., Pointreau Y., Bozec Le Moal L. et al., 2015/09. Annals of oncology : official journal of the European Society for Medical Oncology, 26 (9) pp. 1941-1947.
Gamma Knife surgery versus Linac for brain metastases : which technique for which patient? Analysis of an historical cohort of 63 consecutive patients harbouring 130 lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015/06., 12-th International Stereotactic Radiosurgery Society Congress (ISRS), June 2015, Yokohama, Japan p. 42 dans Journal of Radiosurgery and SBRT.
Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.
Casutt A., Bouchaab H., Beigelman-Aubry C., Bourhis J., Lovis A., Matzinger O., 2015/05. British Journal of Radiology, 88 (1049) p. 20140687. Peer-reviewed.
PO-1102: Toxicity analysis in Helicoidal-IMRT (HT) treatment for head and neck tumors
Tsoutsou P., Ozsahin M., Castella C., Ozsoy O., Khanfir K., Santa Cruz O., 2015/04. Radiotherapy and Oncology, 115 pp. S596.
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
De Bari B., Filippi A.R., Mazzola R., Bonomo P., Trovò M., Livi L., Alongi F., 2015. Cancer Treatment Reviews, 41 (6) pp. 511-518. Peer-reviewed.
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
Blanchard P., Lee A., Marguet S., Leclercq J., Ng W.T., Ma J., Chan A.T., Huang P.Y., Benhamou E., Zhu G. et al., 2015. Lancet. Oncology, 16 (6) pp. 645-655. Peer-reviewed.
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era.
D'Angelillo R.M., Franco P., De Bari B., Fiorentino A., Arcangeli S., Alongi F., 2015. Critical Reviews in Oncology/hematology, 93 (2) pp. 136-148. Peer-reviewed.
Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients.
De Bari B., Lestrade L., Pommier P., Maddalo M., Buglione M., Magrini S.M., Carrie C., 2015. Cancer Investigation, 33 (4) pp. 114-120. Peer-reviewed.
Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.
De Bari B., Vallati M., Gatta R., Simeone C., Girelli G., Ricardi U., Meattini I., Gabriele P., Bellavita R., Krengli M. et al., 2015. Cancer Investigation, 33 (6) pp. 232-240. Peer-reviewed.
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.
Brouwer C.L., Steenbakkers R.J., Bourhis J., Budach W., Grau C., Grégoire V., van Herk M., Lee A., Maingon P., Nutting C. et al., 2015. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology, 117 (1) pp. 83-90. Peer-reviewed.
Gamma Knife Surgery versus Linac for Brain Metastasis: Which Technique for Which Patient? Analysis of an Historical Cohort of 63 Consecutive Patients Harboring 130 Lesions
Levivier M., Tuleasca C., Schiappacasse L., Gevaert T., Faouzi M., Von Elm E., Steenbecke F., Engels B., de Ridder M., Bourhis J., 2015., Joint Annual Meeting 2015: Swiss Society of Neurosurgery and Swiss Society of Neuroradiology Together with IG-NOPPS, Lucerne, Switzerland, 10-11 September 2015 pp. 1-2 dans journal of Neurological Surgery Part A: Central European Neurosurgery.
Gemeinsamkeiten und Unterschiede der primären Radiotherapie beim lokalisierten und lokal fortgeschrittenen Prostatakarzinom in der Schweiz : Eine Analyse der der Behandlungskonzepte Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland : A survey on patterns of practice.
Panje C.M., Dal Pra A., Zilli T., R Zwahlen D., Papachristofilou A., Herrera F.G., Matzinger O., Plasswilm L., Putora P.M., 2015. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], 191 (10) pp. 778-786. Peer-reviewed.
Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.
Ugurluer G., Ballerini G., Moeckli R., Matzinger O., Bourhis J., Ozsahin M., 2015. Tumori, 101 (3) pp. 268-272. Peer-reviewed.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Pless M., Stupp R., Ris H.B., Stahel R.A., Weder W., Thierstein S., Gerard M.A., Xyrafas A., Früh M., Cathomas R. et al., 2015. Lancet, 386 (9998) pp. 1049-1056. Peer-reviewed.
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.
De Bari B., Daidone A., Alongi F., 2015. Critical Reviews in Oncology/hematology, 94 (3) pp. 360-370. Peer-reviewed.
La radiothérapie FLASH pour épargner les tissus sains [The radiotherapy FLASH to save healthy tissues].
Favaudon V., Fouillade C., Vozenin M.C., 2015. Médecine Sciences : M/s, 31 (2) pp. 121-123. Peer-reviewed.
Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy.
Bourgier C., Lacombe J., Solassol J., Mange A., Pèlegrin A., Ozsahin M., Azria D., 2015. Critical Reviews in Oncology/hematology, 93 (3) pp. 312-319. Peer-reviewed.
Multidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.
Garofalo F., di Summa P.G., Christoforidis D., Pracht M., Laudato P., Cherix S., Bouchaab H., Raffoul W., Demartines N., Matter M., 2015. Journal of Surgical Oncology, 112 (5) pp. 544-554. Peer-reviewed.
Méta-analyses d'essais randomisés sur données individuelles dans le traitement des cancers ORL non métastatiques : principes, résultats, perspectives [Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].
Blanchard P., Bourhis J., Lacas B., Le Teuff G., Michiels S., Pignon J.P., 2015. Cancer Radiothérapie, 19 (3) pp. 198-204. Peer-reviewed.
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J., Trigo J., Nuyts S., Ozsahin M., Skladowski K., Hatoum G., Daisne J.F., Yunes Ancona A.C., Cmelak A., Mesía R. et al., 2015. Lancet. Oncology, 16 (2) pp. 221-232. Peer-reviewed.
Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.
Belkacemi Y., Kaidar-Person O., Poortmans P., Ozsahin M., Valli M.C., Russell N., Kunkler I., Hermans J., Kuten A., van Tienhoven G. et al., 2015. Annals of Oncology, 26 (3) pp. 529-535. Peer-reviewed.
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Harrington K., Temam S., Mehanna H., D'Cruz A., Jain M., D'Onofrio I., Manikhas G., Horvath Z., Sun Y., Dietzsch S. et al., 2015. Journal of Clinical Oncology, 33 (35) pp. 4202-4209. Peer-reviewed.
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
Azria D., Riou O., Castan F., Nguyen T.D., Peignaux K., Lemanski C., Lagrange J.L., Kirova Y., Lartigau E., Belkacemi Y. et al., 2015. Ebiomedicine, 2 (12) pp. 1965-1973. Peer-reviewed.
Radiothérapie « flash » à très haut débit de dose : un moyen d'augmenter l'indice thérapeutique par minimisation des dommages aux tissus sains  [Ultrahigh dose-rate, "flash" irradiation minimizes the side-effects of radiotherapy].
Favaudon V., Fouillade C., Vozenin M.C., 2015. Cancer Radiothérapie, 19 (6-7) pp. 526-531. Peer-reviewed.
Re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur urol 2014;65:546-51.
De Bari B., Arcangeli S., Alongi F., 2015. European Urology, 67 (2) pp. e26.
Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P., Bourhis J., Psyrri A., 2015. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting pp. e323-e328. Peer-reviewed.
SBRT and extreme hypofractionation: A new era in prostate cancer treatments?
Alongi F., Fiorentino A., De Bari B., 2015. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 20 (6) pp. 411-416.
Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.
Arshad A., Deutsch E., Vozenin M.C., 2015. Plos One, 10 (1) pp. e0115447. Peer-reviewed.
Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
Pasquier D., Barney B., Sundar S., Poortmans P., Villa S., Nasrallah H., Boujelbene N., Ghadjar P., Lassen-Ramshad Y., Senkus E. et al., 2015. International Journal of Radiation Oncology, Biology, Physics, 92 (4) pp. 904-910. Peer-reviewed.
Unicentre - CH-1015 Lausanne
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University